At RemeGen, Ltd., a leading biotech innovator in China, we believe biologics are the future of medicine—and we're ready to take our therapeutic innovations to the global stage. We're aligning our investments in scientific research, manufacturing and commercialization to change the way cancer, autoimmune and eye diseases are treated. RemeGen is committed to the discovery, development and commercialization of innovative and differentiated biological drugs. We strive to continuously create value through our clinical studies to develop products that meet the unmet clinical needs. We aim to become a global leader in the bio-pharmaceutical industry.